phosphatidylcholines has been researched along with lipoxin a4 in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (lipoxin a4) | Trials (lipoxin a4) | Recent Studies (post-2010) (lipoxin a4) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 833 | 17 | 398 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | lipoxin a4 (IC50) |
|---|---|---|---|
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 0.0001 | |
| N-formyl peptide receptor 2 | Homo sapiens (human) | 0.0119 | |
| Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 0.0001 | |
| Transcription factor p65 | Homo sapiens (human) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afonyushkin, T; Berdyshev, E; Birukov, KG; Birukova, AA; Bochkov, VN; Ke, Y; Meng, F; Oskolkova, O; Sarich, N; Tian, Y; Wang, JM; Zebda, N | 1 |
1 other study(ies) available for phosphatidylcholines and lipoxin a4
| Article | Year |
|---|---|
Anti-Inflammatory Effects of OxPAPC Involve Endothelial Cell-Mediated Generation of LXA4.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Endothelial Cells; Humans; Lipoxins; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphatidylcholines; Treatment Outcome | 2017 |